Statland
Statland ALLISON LONG along@kcstar.com
Statland ALLISON LONG along@kcstar.com

Kansas City native Jeffrey Statland leads research into rare neuromuscular dystrophy

May 03, 2015 12:47 AM

More Videos

  • First treatment that genetically modifies patients’ cells to destroy cancer approved by FDA

    T-cells are one of immune system’s key soldiers, targeting infected or abnormal cells but cancer can block those defenses. Now scientists are genetically modifying patients own cells to make them smarter and tougher at seeking out and destroying cancer. One version is called CAR-T cell therapy, T-cells customized to zero in on a patients specific kind of cancer.